ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 681639 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 681639; 2) Community: the network communities that were significantly associated with the response to NSC 681639; 3) Molecule: the relationships between components within communities and NSC 681639; 4) MDR: the compounds that were significantly associated with the NSC 681639.

NSC Compound Enrichment Correlation
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0209467683758286 0.3559884
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0209467683758286 0.53461609
NSC 606499 Camptothecin Derivative 0.0209467683758286 0.90584424
NSC 615534 Null 0.0209467683758286 0.16137227
NSC 619030 Analog of CC-1065 0.0209467683758286 0.74514048
NSC 674182 Null 0.0209467683758286 0.69881095
NSC 678869 Benz[a]anthracene-6,6-dicarboxylic acid, 5,6,7,12- tetrahydro-2-methoxy-7,12-dioxo-, dimethyl ester 0.0209467683758286 0.10670185
NSC 681632 Camptothecin Derivative 0.0209467683758286 0.85745299
NSC 694620 Null 0.0209467683758286 0.068193405
NSC 715974 Null 0.0209467683758286 0.37402288
Total:56  Current:26    [First] [Prev] [Next] [Last]